In patients who did not receive radiotherapy, there was no statistically significant difference in survival between the two groups (Fig. 4G, P = 0.2432), this may be due to the low number of IDH-mutant astrocytoma patients. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).